Patents by Inventor Lujian TAN

Lujian TAN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical combinations
    Patent number: 9446043
    Abstract: A pharmaceutical combination comprising (a) a protein kinase C (PKC) inhibitor compound, or a pharmaceutically acceptable salt thereof, and (b) at least one mitogen activated protein kinase (MEK) inhibitor or a pharmaceutically acceptable salt, and optionally a pharmaceutically acceptable carrier, for simultaneous, separate or sequential administration; the uses of such combination in the treatment of proliferative diseases; and methods of treating a subject suffering from a proliferative disease comprising administering a therapeutically effective amount of such combination.
    Type: Grant
    Filed: November 26, 2013
    Date of Patent: September 20, 2016
    Assignee: Novartis AG
    Inventors: Dale Porter, Caroline Emery, Lujian Tan, Padmaja Yerramilli-Rao
  • Pharmaceutical Combinations
    Publication number: 20150306101
    Abstract: A pharmaceutical combination comprising (a) a protein kinase C (PKC) inhibitor compound, or a pharmaceutically acceptable salt thereof, and (b) at least one mitogen activated protein kinase (MEK) inhibitor or a pharmaceutically acceptable salt, and optionally a pharmaceutically acceptable carrier, for simultaneous, separate or sequential administration; the uses of such combination in the treatment of proliferative diseases; and methods of treating a subject suffering from a proliferative disease comprising administering a therapeutically effective amount of such combination.
    Type: Application
    Filed: November 26, 2013
    Publication date: October 29, 2015
    Inventors: Dale PORTER, Caroline EMERY, Lujian TAN, Padmaja YERRAMILLI-RAO